Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
- PMID: 27445821
- PMCID: PMC4923250
- DOI: 10.3389/fphar.2016.00185
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
Abstract
Poly(lactic-co-glycolic acid) (PLGA) is the most widely used biomaterial for microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens. PLGA has excellent biodegradability and biocompatibility and is generally recognized as safe by international regulatory agencies including the United States Food and Drug Administration and the European Medicines Agency. The physicochemical properties of PLGA may be varied systematically by changing the ratio of lactic acid to glycolic acid. This in turn alters the release rate of microencapsulated therapeutic molecules from PLGA microparticle formulations. The obstacles hindering more widespread use of PLGA for producing sustained-release formulations for clinical use include low drug loading, particularly of hydrophilic small molecules, high initial burst release and/or poor formulation stability. In this review, we address strategies aimed at overcoming these challenges. These include use of low-temperature double-emulsion methods to increase drug-loading by producing PLGA particles with a small volume for the inner water phase and a suitable pH of the external phase. Newer strategies for producing PLGA particles with high drug loading and the desired sustained-release profiles include fabrication of multi-layered microparticles, nanoparticles-in-microparticles, use of hydrogel templates, as well as coaxial electrospray, microfluidics, and supercritical carbon dioxide methods. Another recent strategy with promise for producing particles with well-controlled and reproducible sustained-release profiles involves complexation of PLGA with additives such as polyethylene glycol, poly(ortho esters), chitosan, alginate, caffeic acid, hyaluronic acid, and silicon dioxide.
Keywords: PLGA microparticles; biodegradation mechanisms; drug delivery system; hydrogel template; hydrophilic molecule; microfluidics; supercritical carbon dioxide; tuneable release.
Similar articles
-
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.Mol Pharm. 2016 Sep 6;13(9):2923-40. doi: 10.1021/acs.molpharmaceut.6b00335. Epub 2016 Jun 22. Mol Pharm. 2016. PMID: 27286558
-
Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.Eur J Pharm Biopharm. 2017 Jun;115:177-185. doi: 10.1016/j.ejpb.2017.02.021. Epub 2017 Mar 2. Eur J Pharm Biopharm. 2017. PMID: 28263795
-
Three-dimensional poly(lactic-co-glycolic acid)/silica colloidal crystal microparticles for sustained drug release and visualized monitoring.J Colloid Interface Sci. 2018 Nov 15;530:465-472. doi: 10.1016/j.jcis.2018.05.102. Epub 2018 May 30. J Colloid Interface Sci. 2018. PMID: 29990782
-
Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles.ACS Biomater Sci Eng. 2020 Nov 9;6(11):6053-6062. doi: 10.1021/acsbiomaterials.0c01228. Epub 2020 Oct 9. ACS Biomater Sci Eng. 2020. PMID: 33449671 Review.
-
Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.J Pharm Sci. 2018 Feb;107(2):513-528. doi: 10.1016/j.xphs.2017.10.012. Epub 2017 Oct 16. J Pharm Sci. 2018. PMID: 29045885 Free PMC article. Review.
Cited by
-
Sustained release ketamine-loaded porous silicon-PLGA microparticles prepared by an optimized supercritical CO2 process.Drug Deliv Transl Res. 2022 Mar;12(3):676-694. doi: 10.1007/s13346-021-00991-w. Epub 2021 Apr 28. Drug Deliv Transl Res. 2022. PMID: 33907987
-
Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy.Pharmaceutics. 2020 Jul 27;12(8):706. doi: 10.3390/pharmaceutics12080706. Pharmaceutics. 2020. PMID: 32727014 Free PMC article.
-
Microfluidic Production of Polymeric Core-Shell Microspheres for the Delayed Pulsatile Release of Bovine Serum Albumin as a Model Antigen.Pharmaceutics. 2021 Nov 3;13(11):1854. doi: 10.3390/pharmaceutics13111854. Pharmaceutics. 2021. PMID: 34834269 Free PMC article.
-
PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs.Front Pharmacol. 2018 Feb 9;8:1002. doi: 10.3389/fphar.2017.01002. eCollection 2017. Front Pharmacol. 2018. PMID: 29479316 Free PMC article. Review.
-
Evaluation of recombinant human vascular endothelial growth factor VEGF121-loaded poly-l-lactide microparticles as a controlled release delivery system.Turk J Biol. 2020 Feb 17;44(1):34-47. doi: 10.3906/biy-1908-32. eCollection 2020. Turk J Biol. 2020. PMID: 32123494 Free PMC article.
References
-
- Anderson J. M., Shive M. S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5–24. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources